An eight‐week, multicenter, randomized, double‐blind study to evaluate the efficacy and tolerability of fixed‐dose amlodipine/benazepril combination in comparison with amlodipine as first‐line therapy in Chinese patients with mild to moderate hypertension

References

• MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., et al. Blood pressure, stroke, and coronary heart disease: Prolonged differences in blood pressure. Lancet 1990; 335: 765–774
   PubMed Web of Science ®Google Scholar
• Stamler J., Stamler R., Neaton J. D. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med 1993; 153: 598–615
   PubMed Web of Science ®Google Scholar
• Collins R., Peto R., MacMahon S., Hebert P., Fiebach N. H., Eberlein K. A., et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short‐term reductions in blood pressure: Overview of randomized drug trials in their epidemiological context. Lancet 1990; 335: 827–838
   PubMed Web of Science ®Google Scholar
• Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105–1187
   PubMed Web of Science ®Google Scholar
• World Health Organization International Society of Hypertension Writing Group. World Health Organization (WHO)/ International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983–1992
   PubMed Web of Science ®Google Scholar
• Chobanian A. V., Bakris G. L., Black H. R., Cushman W. C., Green L. A., Izzo J. L., Jr., et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 2003; 289: 2560–2572
   PubMed Web of Science ®Google Scholar
• Law M. R., Wald N. J., Morris J. K., Jordan R. E. Value of low dose combination treatment with blood pressure lowering drugs: Analysis of 354 randomised trials. BMJ 2003; 326: 1427–1435
   PubMed Web of Science ®Google Scholar
• Frishman W. H., RAM C. V., McMahon F. G., Chrysant S. G., Graff A., Kupiec J. W., et al. Comparison of amlodipine and benazepril monotherapy to amlodipine plus benazepril in patients with systemic hypertension: A randomized, double‐blind, placebo‐controlled, parallel‐group study. The Benazepril/Amlodipine Study Group. J Clin Pharmacol 1995; 35: 1060–1066
   PubMed Web of Science ®Google Scholar
• Kuschnir E., Acuña E., Sevilla D., Vasquez J., Bendersky M., Resk J., et al. Treatment of patients with essential hypertension: Amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo. Clin Ther 1996; 18: 1213–1224
   PubMed Web of Science ®Google Scholar
• Messerli F. H., Oparil S., Feng Z. Comparison of efficacy and side effects of combination therapy of angiotensin‐converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high‐dose calcium antagonist monotherapy for systemic hypertension. Am J Cardiol 2000; 86: 1182–1187
   PubMed Web of Science ®Google Scholar
• Pool J., Kaihlanen P., Lewis G., Ginsberg D., Oparil S., Glazer R., et al. Once‐daily treatment of patients with hypertension: A placebo‐controlled study of amlodipine and benazepril vs amlodipine or benazepril alone. J Hum Hypertens 2001; 15: 495–498
   PubMed Web of Science ®Google Scholar
• Messerli F. H., Weir M. R., Neutel J. M. Combination therapy of amlodipine/benazepril versus monotherapy of amlodipine in a practice‐based setting. Am J Hypertens 2002; 15: 550–556
   PubMed Web of Science ®Google Scholar
• Chrysant S. G., Bakris G. L. Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy. Am J Hypertens 2004; 17: 590–596
   PubMed Web of Science ®Google Scholar
• Jamerson K. A., Nwose O., Jean‐Louis L., Schofield L., Purkayastha D., Baron M. Initial angiotensin‐converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension. Am J Hypertens 2004; 17: 495–501
   PubMed Web of Science ®Google Scholar
• Neutel J. M., Smith D. H., Weber M. A., Schofield L., Purkayastha D., Gatlin M. Efficacy of combination therapy for systolic blood pressure in patients with severe systolic hypertension: The Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) study. J Clin Hypertens 2005; 7: 641–646
   PubMedGoogle Scholar
• Dahlof B., Sever P. S., Poulter N. R., Wedel H., Beevers D. G., Caulfield M., et al. ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo‐Scandinavian Cardiac Outcomes Trial‐Blood Pressure Lowering Arm (ASCOT‐BPLA): A multicentre randomised controlled trial. Lancet 2005; 366: 895–906
   PubMed Web of Science ®Google Scholar
• Balfour J. A., Goa K. L. Benazepril: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in hypertension and congestive heart failure. Drugs 1991; 42: 511–539
   PubMed Web of Science ®Google Scholar
• Murdoch D., Heel R. C. Amlodipine: A review of its pharmacodynamic properties and therapeutic use in cardiovascular disease. Drugs 1991; 41: 478–505
   PubMed Web of Science ®Google Scholar
• Sile S., Velez D. R., Gillani N. B., Alexander C. A., George A. L., Jr., Williams S. M. Haplotype diversity in four genes (CLCNKA, CLCNKB, BSND, NEDD4L) involved in renal salt reabsorption. Hum Hered 2008; 65: 33–46
   PubMed Web of Science ®Google Scholar
• Chan P., Lin C. N., Tomlinson B., Lin T. H., Lee Y. S. Additive effects of diltiazem and lisinopril in the treatment of elderly patients with mild‐to‐moderate hypertension. Am J Hypertens 1997; 10: 743–749
   PubMed Web of Science ®Google Scholar
• Lee Y. J., Tsai J. C. Angiotensin‐converting enzyme gene insertion/deletion, not bradykinin B2 receptor‐58T/C gene polymorphism, associated with angiotensin‐converting enzyme inhibitor‐related cough in Chinese female patients with non‐insulin‐dependent diabetes mellitus. Metabolism 2001; 50: 1346–1350
   PubMed Web of Science ®Google Scholar
• Pedrinelli R., Dell'Omo G., Melillo E., Mariani M. Amlodipine, enalapril, and dependent leg edema in essential hypertension. Hypertension 2000; 35: 621–625
   PubMed Web of Science ®Google Scholar
• Lund‐Johansen P., Stranden E., Helberg S., Wessel‐Aas T., Risberg K., Rønnevik P. K., et al. Quantification of leg oedema in postmenopausal hypertensive patients treated with lercanidipine or amlodipine. J Hypertens 2003; 21: 1003–1010
   PubMed Web of Science ®Google Scholar
• Kloner R. A., Sowers J. R., DiBona G. F., Gaffney M., Wein M. Sex‐ and age‐related antihypertensive effects of amlodipine. The Amlodipine Cardiovascular Community Trial Study Group. Am J Cardiol 1996; 713–722, 77
   PubMedGoogle Scholar
• Taylor A. A., Shoheiber O. Adherence to antihypertensive therapy with fixed‐dose amlodipine besylate/benazepril HCl versus comparable component‐based therapy. Congest Heart Fail 2003; 9: 324–332
   PubMedGoogle Scholar
• Park S., Chung N., Kwon J., Yoon J. H., Kim Y. J., Han D. S., et al. Results of a multicenter, 8‐week, parallel‐group, randomized, double‐blind, double‐dummy, Phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension. Clin Ther 2005; 27: 441–450
   PubMed Web of Science ®Google Scholar